In order to investigate the effect of angiotensin receptor blockage (ARB) for the treatment on diabetic erectile dysfunction (ED), we used male Sprague-Dawley rats injected with 65 mg/kg streptozotocin to induce diabetes mellitus. The diabetic rats with ED were selected by hypodermic injection of apomorphine (APO) after 8 weeks of model setting. All rats were divided into four groups: G1 (normal control rats), G2 (diabetic rats treated with normal saline), G3 (diabetic rats treated with valsartan) and G4 (diabetic rats treated with spironolactone). After treatment with drugs for 8 weeks, the rate of erection for each group was evaluated after the injection of APO. The intracavernous pressure (ICP) of each rat was then recorded before and after the electrostimulation of the major pelvic ganglion. The rates of erection and the ICP after electrostimulation for diabetic rats treated with valsartan were significantly higher than that in diabetic rats treated with normal saline and spironolactone. The ARB may be an effective therapy for diabetics with ED.
Introduction
Erectile dysfunction (ED) is one of the most common chronic complications in diabetic men. Diabetic men are three times as likely to have ED as nondiabetic men. 1 The pathogenesis of diabetic ED is not clearly known. Several factors may play important roles to induce diabetic ED such as neural, vascular, endocrine and metabolic changes. Among them, the vascular change is the basal pathological change of diabetic ED. Salama and Kagawa 2 found ultrastructural changes in the collagen of penile tunica albuginea in diabetic rats: a significant gradual increase in bundle thickness and loss of its undulation.
The renin-angiotensin system (RAS) exists in many organs, including the heart, kidneys and reproductive organs. 3 Angiotensin II (Ang II) is formed from angiotensin I (Ang I) by angiotensin I-converting enzyme (ACE). Ang II and Ang I induce contractions of vascular smooth muscles. Park et al. 4 found that the RAS is involved in the regulation of corpus cavernosum smooth muscle tone of rabbits. They believed that the Ang II receptor subtype (AT1R) is important in the regulation of penile erection. The similar result was found in the rabbit clitoral cavernosum. 5 The RAS inhibitor was found to partially normalize penile vascular structure. 6 Our previous study showed that the Ang II level in penile tissue of diabetic rats with ED was significantly higher than that in the normal control or diabetic rats without ED. 7 Ang II induced ED in diabetic rats by activation of AT1R. Valsartan is an effective antagonist of AT1R and this study was designed to evaluate effect of valsartan to treat ED in diabetic rats.
Materials and methods

Animals and treatment
The study protocol was approved by the institutional animal care committee. Fifty male Sprague-Dawley rats weighing 200-250 g were obtained from Shanghai Slac Laboratory Animal Co. Ltd. Forty rats were selected randomly and injected intraperitoneally with freshly prepared streptozotocin (STZ) (65 mg/kg). The rest of them (G1 group, n ¼ 10) were treated with vehicle (0.1 mol/l citrate-phosphate buffer, pH 4.5) as a control group. All rats were kept in a temperature-controlled, air-conditioned, conventional animal house with a 12-h light-dark cycle; and were given free access food and water.
Seventy-two hours after injection, the blood glucose level was monitored at regular intervals throughout the study and immediately before being killed. Only the STZ-induced diabetic rats with serum glucose levels more than 16.6 mol/l were included in the study. Among the 40 STZ-injected rats, 35 with serum glucose higher than 16.6 mol/l were randomly divided into three groups and treated with different agents: G2 (diabetic rats with normal saline, n ¼ 11), G3 (diabetic rats with valsartan, n ¼ 12) and G4 (diabetic rats with spironolactone, n ¼ 12). The rats were treated with normal saline (G1 and G2), valsartan (G3) and spironolactone (G4) by intragastric administration every day for 8 weeks.
Apomorphine test
Eight weeks after treatment, the apomorphine (APO) test was performed.
8 APO (Sigma, St Louis, MO, USA) was dissolved in normal saline solution (0.2 g/l ascorbic acid and 10 mg/ml APO) and stored in the cool and dark place. The room light was dimmed except for some indirect light sufficient for observation. After a 10-min habituation period, the rat was injected with APO (80 mg/kg) subcutaneously in the loose skin at the back of the neck. The animal was observed by two different people for 30 min or until erectile response occurred, whichever came first. An erection was only counted when the emergence of an engorged glans penis and distal shaft was seen. The yawn was counted when breathing with obviously big mouth and apparent respiration movement was noticed. The rates of erection and yawn of rats in each group were recorded.
Intracavernous pressure measurement
After the APO test, the intracavernous pressures (ICPs) of rats in each group were measured. Under urethane anesthesia (0.9 mg/kg), a carotid artery was cannulated (PE-50 tubing) for the measurement of mean systemic arterial pressure (MAP). The major pelvic ganglion, cavernous nerves and pelvic organs were exposed. The skin overlying the penis was removed and the right penile crus was exposed by removing part of the overlying ischiocavernous muscle. A 23-gauge needle connected to a PE-50 tube with heparinized saline (250 IU/ml) was carefully inserted into the crus. The other end of the PE-50 tube was connected to a pressure monitor. The cavernous nerve electrostimulation was performed with a stainless-steel bipolar hook electrode at the standard setting (20 Hz, pulse width 5 ms, 5 V and duration 60 s). The MAP and ICP were measured and recorded by computer.
Radioimmunoassay for Anga
After the ICP measurement, 2 ml venous blood samples were obtained from a femoral vein of the rats in G1 and G2 groups. Blood samples were immediately stored on ice and centrifuged at 41C, 3000 r.p.m., for 10 min. The plasma was separated and stored at À801C until analysis. (The rat penises were removed without skin and glans and stored at À801C for subsequent assessment.) After the cavernous tissue had been homogenated and centrifugated, the supernatant was extracted and stored at 41C.
The Ang II levels in both the plasma and supernatant of cavernous tissue were determined using the radioimmunoassay (RIA) kit (Angiotensin II radioimmunoassay, Beijing North Institute of Biological Technology, Beijing, China) according to the manufacturer's manual. It contained 125 I-angiotensin II and rabbit anti-ANG II antibody with crossreactivity of o2% for Ang II precursors and degradation products. The supernatant was counted with a g-counter (USTC Chuangxin, Co., Ltd, Hefei City, Anhui Province, China). The ratio B/B 0 was corrected for non-specific binding, expressed as a percentage of maximal binding, and read against a standard curve (log-logit transformation).
Statistical analysis
Values were expressed as mean7s.d. In comparisons between multiple groups, one-way analysis of variance was used. The Student's t-test was used for two group comparisons. All statistical analyses were processed through the Statistical Package for the Social Sciences, version 13.0, for Windows (SPSS). A P-value less than 0.05 was considered statistically significant.
Results
STZ-induced diabetic rats
Among the 40 STZ-induced rats, 35 with serum glucose higher than 16.6 mol/l developed hyperglycemia, hyperuresis, weight loss and elevated levels of food and water intake compared to the control. The body weight and serum glucose level of the rats was shown in Table 1 . During the study, four rats (one in the G2 group, two in the G3 group and one in the G4 group) died of hyperglycemia and other reasons.
Reverse
APO test
The rates and frequency of erection of each group after hypodermic injection of apomorphine were reported in Figure 1 . The erectile rates of G2 group and G3 group were lower than that of G1 group. The erectile rate of G3 group was higher than that of G2 and G4 groups, but lower than G1 group. The erectile frequency of G2 or G4 group was significantly decreased (Po0.05), compared to that of the G1 group. The erectile frequency of G3 group (Valsartan) was significantly increased, compared to that of the G2 and G4 groups (Po0.05).
ICP determination
The baseline ICP showed no difference among these four groups. The ratio of maximal ICP/MAP after electrostimulation of the rats in the G3 group was significantly higher than in the G2 and G4 groups (Po0.05). There was no difference of the maximal ICP/MAP between G2 and G4 groups (Figure 2) .
The Ang II level of plasma and cavernous tissue by RIA Compared to the normal control (G1) group (763.1752.2), the Ang II plasma levels in rats with diabetic ED (G2) group (860.9772.1) were significantly increased (Po0.05). The Ang II levels in the cavernous tissue in the G2 rats (1972.67202.4) were also significantly increased (Po0.05) compared to the levels in the G1 group (1382.87158.5) (Figure 3 ).
Discussion
It was well known that the renin-angiotensin aldosterone system (RAAS) was classically charac- G4 G3 G1 G2 G4 G3 Figure 2 The maximal ICP of each group before and after the electrostimulation of the major pelvic ganglion. The ICP of G3 group (Valsartan treatment) was significantly increased, compared to that of the G2 and G4 groups. **Po0.05 vs G1 group; ## Po0.05 vs G3 group.
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Y Chen et al terized as a circulating hormonal system, primarily through the production of the physiologically active Ang II, which regulates blood pressure (BP), circulating fluid and electrolyte homeostasis. The prehypertensin is hydrolyzed by renin and transformed into angiotensin I (Ang I). Ang I has no effect in regulating the BP. Ang I is converted to angiotensin II (Ang II) by the ACE. When Ang II binds to the angiotensin type 1 receptor (AT1R) it can cause vessel contraction that regulates the BP. ACE inhibitors (ACEI) block the activity of ACE and prevent Ang I from transforming to Ang II, resulting in the BP decreasing. Angiotensin receptor blockers (ARB) obstruct the combination of Ang II to AT1R, and subsequently cause a similar physiological effect.
In addition to the RAAS in the circulatory system, the local RAS or RAAS was recently proven to exist in many tissues such as the heart, vasculature, 9 ureter 10 and prostate. 11 Local RAS were also found in endothelial and smooth muscle cells of cavernous tissues. Kifor et al. 12 reported that the corpus cavernosum produced and secreted physiologically relevant amounts of Ang II. They used the exogenous Ang II by intracavernosal injection and found that it caused contraction of cavernosal smooth muscle and terminated spontaneous erection of dogs, whereas administration of an Ang II receptor antagonist resulted in smooth muscle relaxation and erection. Park et al. 4 suggested that the local RAS was involved in the regulation of corpus cavernosum smooth muscle tone of rabbit and the Ang II receptor subtype AT1R was important in the regulation of penile erection. In healthy men, the Ang II levels in the cavernous plasma of every stage of erection were all higher than those in peripheral plasma. 13 Because of the short half-life of Ang II, the Ang II in the cavernous plasma was not from blood circulation, but was produced in the penile tissue. The Ang II levels in venous blood of patients with ED were significantly higher than those of normal persons, and the Ang II levels in cavernosal blood of patients with organic ED were higher than those of patients with psychogenic ED. 14 The pathogenesis of diabetic ED is multifactorial, including neural, vascular, endocrine and metabolic changes. The impaired vascular system is foremost in the development of ED in diabetic patients. In our primary study, 7 we found that the Ang II level of diabetic ED rat penises was significantly higher than those of normal control rats. The local RAS plays an important role in the mechanism of diabetic ED.
Is there any medicine that can correct the abnormal RAS to treat vasogenic ED caused by diabetes? In this study, we chose one of the ARBs, valsartan, to treat the rats with diabetic ED, compared to the treatment of spironolactone to exclude the effect of system and BP control. Spironolactone is used as an aldosterone-antagonist diuretic in hypertension treatment. Valsartan is also an antihypertensive agent. Comparison between spironolactone and valsartan can exclude the antihypertension effect of valsartan.
This study demonstrated that valsartan had significant effect on improving the erectile function of diabetic ED rats. Valsartan, as an antagonist of AT1R, blockades the combination of Ang II and AT1R and antagonizes the high level of Ang II. These results also support that Ang II is important to the pathogenesis of diabetic ED and suggest that ARB may be used to treat diabetic patients with ED.
ACEI, such as enalapril 6 and captopril, 15 were found to reverse ED in spontaneously hypertensive rats and induce the structural remodeling of the penile structure. ARBs, such as losartan and candesartan have the similar pharmacological effect. Losartan protects the structural changes in vessels and cavernous spaces of the erectile tissue caused by arterial hypertension, 16 and improves the erectile function. 17 Losartan can also restore the erectile capacity in normotension aged rats. 18 Losartan improves erectile function of hypertensive men with ED and increases the satisfaction and frequency of sexual activity. 19 Toblli et al. 20 reported that candesartan cilexetil had a significant protective role against morphologic changes in vessels and in cavernous tissue in hypertensive rats. Our study found that valsartan, as an antagonist of AT1R, could also improve erectile function of diabetic ED.
The pathogenesis of diabetic ED is complex and not fully clear. 21 The vascular factor certainly plays an important role. In extracavernosal vascular tissue, smooth muscle tone is modulated by a 
Groups
Error bars: +/-2.00 SD measuring unit: Blood plasma (pg/ml), Penile tissue (pg/g) Figure 3 Ang II levels of blood plasma and penile tissue. The Ang II levels of plasma and cavernous tissue in G2 group were both significantly increased compared to G1 group. **Po0.05 vs G1 group.
Reverse of erectile dysfunction in diabetic rats Y Chen et al balance between Ang II and nitric oxide (NO). Comiter et al. 22 reported that Ang II caused a dosedependent contraction of cavernosal smooth muscle, which was inhibited by ARB and augmented by NOS inhibition. Parks et al. 4 believed that Ang II is the most potent factor causing cavernosal smooth muscle contraction via activation of AT1R. 4, 5, 23 As shown in our study, blockage of AT1R may interrupt the contracting effect of Ang II and reverse the vascular structure of diabetic ED rats.
In conclusion, there are local RAS in the penis. Ang II plays an important role in the pathogenesis of diabetic ED through articulation of AT1R. Ang II level in diabetic rats with ED was higher than that in normal rats and diabetic rats without ED. ARB treatment can reverse ED of diabetic ED rats.
